ENHANCING ONCOLOGY INVESTIGATE WITH BUILT-IN KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

within the rapidly evolving subject of oncology study, correct and economical mutation screening is crucial for building qualified therapies. The KRAS companies System plays a pivotal purpose in this landscape by providing in depth options for KRAS mutation profiling and Investigation. KRAS mutations, found in somewhere around 95% of RAS-relevant o